Mediclinic Southern Africa is a private hospital group operating in South Africa and Namibia focused on providing acute care, specialist-orientated, multi-disciplinary hospital services and related service offerings. We place science at the heart of our care process by striving to provide evidence-based care of the highest standard. The group currently operates 50 private hospitals and five day clinics throughout South Africa and 3 private hospitals in Namibia, with more than 8 000 beds in total.
Mediclinic Southern Africa is a wholly owned subsidiary of the international private healthcare group Mediclinic International PLC, listed on the LSE (London Stock Exchange) with a secondary listing on the JSE (Johannesburg Stock Exchange) and the NSX (Namibian Stock Exchange).
Mediclinic International currently has three operating divisions – Mediclinic Southern Africa which operates 53 private hospitals and five day clinics throughout South Africa and Namibia; Hirslanden operates 17 private acute care facilities and four clinics in Switzerland with more than 1 800 inpatient beds and Mediclinic Middle East which operates six hospitals and 22 clinics with more than 700 inpatient beds in the United Arab Emirates.
The group also holds a minority interest of 29.9% in Spire Healthcare Group PLC, a leading private hospital group in the United Kingdom, which is also listed on the LSE.